MedPath

PRUDENTLINK LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

PPB:26

Drug Approvals

NAPROXEN TABLETS 250MG

Approval Date
Feb 26, 2022
PPB

MOMETA CREAM 0.1% W/W

Approval Date
Jan 20, 2022
PPB

PREDNISOLONE TABLETS 5MG

Approval Date
Aug 31, 2021
PPB

PREDNISOLONE TABLETS 5MG

Approval Date
Mar 27, 2019
PPB

DEXTROMETHORPHAN HYDROBROMIDE ELIXIR 15MG/5ML

Approval Date
Jan 3, 2019
PPB

MEFENAMIC ACID CAPSULES 250MG

Approval Date
Nov 22, 2018
PPB

CHLORPHENAMINE MALEATE TABLETS 4MG

Approval Date
Sep 12, 2018
PPB

PROCHLORPERAZINE MALEATE TABLETS 5MG

Approval Date
Aug 2, 2018
PPB

NAPROXEN TABLETS 250MG

Approval Date
Jul 4, 2018
PPB

DIMENHYDRINATE TABLETS 50MG

Approval Date
Jun 1, 2018
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.